Published in J Pediatr on June 12, 2011
Docosahexaenoic Acid (DHA) Supplementation in High Risk Pregnancies | NCT04069195
Beyond building better brains: bridging the docosahexaenoic acid (DHA) gap of prematurity. J Perinatol (2014) 0.91
Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury. PLoS One (2014) 0.88
Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease. Adv Nutr (2014) 0.85
What is the relationship between gestational age and docosahexaenoic acid (DHA) and arachidonic acid (ARA) levels? Prostaglandins Leukot Essent Fatty Acids (2015) 0.83
Dietary ω-3 polyunsaturated fatty acids decrease retinal neovascularization by adipose-endoplasmic reticulum stress reduction to increase adiponectin. Am J Clin Nutr (2015) 0.82
The Essentiality of Arachidonic Acid in Infant Development. Nutrients (2016) 0.82
Daily Enteral DHA Supplementation Alleviates Deficiency in Premature Infants. Lipids (2016) 0.82
Randomized controlled trial of docosahexaenoic acid supplementation in midwestern U.S. human milk donors. Breastfeed Med (2012) 0.82
Nutrition, insulin-like growth factor-1 and retinopathy of prematurity. Semin Fetal Neonatal Med (2013) 0.80
The impact of dietary long-chain polyunsaturated fatty acids on respiratory illness in infants and children. Curr Allergy Asthma Rep (2012) 0.80
Review of Infant Feeding: Key Features of Breast Milk and Infant Formula. Nutrients (2016) 0.77
The Role of Immunonutrients in the Prevention of Necrotizing Enterocolitis in Preterm Very Low Birth Weight Infants. Nutrients (2015) 0.77
Maternal dietary DHA supplementation to improve inflammatory outcomes in the preterm infant. Adv Nutr (2012) 0.77
Factors Determining Optimal Fatty Acid Absorption in Preterm Infants. J Pediatr Gastroenterol Nutr (2016) 0.76
Comparison of the nutrient composition of commercial dog milk replacers with that of dog milk. J Am Vet Med Assoc (2014) 0.76
Late Enteral Feedings Are Associated with Intestinal Inflammation and Adverse Neonatal Outcomes. PLoS One (2015) 0.75
Effects of Nucleotides Supplementation of Infant Formulas on Plasma and Erythrocyte Fatty Acid Composition: A Meta-Analysis. PLoS One (2015) 0.75
Lactational Stage of Pasteurized Human Donor Milk Contributes to Nutrient Limitations for Infants. Nutrients (2017) 0.75
Can maternal DHA supplementation offer long-term protection against neonatal hyperoxic lung injury? Am J Physiol Lung Cell Mol Physiol (2015) 0.75
Early docosahexaenoic and arachidonic acid supplementation in extremely-low-birth-weight infants. Pediatr Res (2016) 0.75
Two-Year Neurodevelopment and Growth Outcomes for Preterm Neonates Who Received Low-Dose Intravenous Soybean Oil. JPEN J Parenter Enteral Nutr (2016) 0.75
Use of a novel docosahexaenoic acid formulation vs control in a neonatal porcine model of short bowel syndrome leads to greater intestinal absorption and higher systemic levels of DHA. Nutr Res (2017) 0.75
Early postnatal docosahexaenoic acid levels and improved preterm brain development. Pediatr Res (2016) 0.75
Plasma arachidonic and docosahexaenoic acids in Tunisian very low birth weight infants: status and association with selected neonatal morbidities. J Health Popul Nutr (2015) 0.75
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation. BMC Pediatr (2016) 0.75
ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases. Am J Clin Nutr (2017) 0.75
Alveolar formation is dysregulated by restricted nutrition but not excess sedation in preterm lambs managed by noninvasive support. Pediatr Res (2016) 0.75
Lipoxin A4 Attenuates Bronchopulmonary Dysplasia via Upregulation of Let-7c and Downregulation of TGF-β1 Signaling Pathway. Inflammation (2017) 0.75
Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics (2010) 9.15
Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA (2002) 8.15
The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) (2008) 5.50
SNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores. J Pediatr (2001) 4.82
Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med (2007) 4.36
Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med (2004) 4.09
Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev (2010) 3.30
Polyunsaturated fatty acids, inflammation, and immunity. Lipids (2001) 2.08
Essential fatty acids in growth and development. Prog Lipid Res (1991) 1.74
Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci U S A (1996) 1.71
The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids (2008) 1.65
Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev (1980) 1.62
Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics (2006) 1.60
Fatty acid supply to the human fetus. Annu Rev Nutr (2010) 1.53
Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA (2009) 1.47
Nutritional practices and growth velocity in the first month of life in extremely premature infants. Pediatrics (2009) 1.28
Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr Opin Organ Transplant (2010) 1.18
Long chain polyunsaturated fatty acid formation in neonates: effect of gestational age and intrauterine growth. Pediatr Res (2000) 1.16
Polyunsaturated fatty acid supplementation alters proinflammatory gene expression and reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Pediatr Res (2007) 1.10
Fat and fatty acid requirements and recommendations for infants of 0-2 years and children of 2-18 years. Ann Nutr Metab (2009) 1.05
Optimizing DHA levels in piglets by lowering the linoleic acid to alpha-linolenic acid ratio. J Lipid Res (2002) 1.04
The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids. Pediatr Res (1996) 1.03
Plasma and red blood cell fatty acid of very low birth weight infants fed exclusively with expressed preterm human milk. Pediatr Res (1996) 0.97
Estimation of arachidonic acid synthesis in full term neonates using natural variation of 13C content. J Pediatr Gastroenterol Nutr (1995) 0.97
Infant formula supplementation with long-chain polyunsaturated fatty acids has no effect on Bayley developmental scores at 18 months of age--IPD meta-analysis of 4 large clinical trials. J Pediatr Gastroenterol Nutr (2010) 0.97
Role of long-chain polyunsaturated fatty acids in neurodevelopment and growth. Nestle Nutr Workshop Ser Pediatr Program (2010) 0.94
Fatty acid patterns early after premature birth, simultaneously analysed in mothers' food, breast milk and serum phospholipids of mothers and infants. Lipids Health Dis (2009) 0.92
Resolvins as regulators of the immune system. ScientificWorldJournal (2010) 0.92
Competition between 24:5n-3 and ALA for Delta 6 desaturase may limit the accumulation of DHA in HepG2 cell membranes. J Lipid Res (2007) 0.92
Plausible explanations for effects of long chain polyunsaturated fatty acids (LCPUFA) on neonates. Arch Dis Child Fetal Neonatal Ed (1999) 0.92
Docosahexaenoic acid status of preterm infants at birth and following feeding with human milk or formula. Am J Clin Nutr (1986) 0.88
Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial. Am J Clin Nutr (2010) 0.88
Fatty acid profiles, antioxidant status, and growth of preterm infants fed diets without or with long-chain polyunsaturated fatty acids. A randomized clinical trial. Eur J Nutr (2003) 0.84
Influence of fatty acid profile of total parenteral nutrition emulsions on the fatty acid composition of different tissues of piglets. Lipids (2008) 0.83
Some aspects of neonatal essential fatty acid status are altered by linoleic acid supplementation of women during pregnancy. J Nutr (1995) 0.81
Neonatal polyunsaturated fatty acid metabolism. Lipids (1999) 0.81
Effect of three intravenously administered fat emulsions containing different concentrations of fatty acids on the plasma fatty acid composition of premature infants. J Pediatr (1994) 0.80
Fatty acid composition of plasma and red cell phospholipids of preterm babies fed on breast milk and formulae. Eur J Pediatr (1995) 0.79
Medium-chain triacylglycerols in formulas for preterm infants: effect on plasma lipids, circulating concentrations of medium-chain fatty acids, and essential fatty acids. Am J Clin Nutr (1996) 0.79
Factors affecting long-chain polyunsaturated fatty acid composition of plasma choline phosphoglycerides in preterm infants. J Pediatr Gastroenterol Nutr (1992) 0.79
Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med (2007) 12.55
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med (2010) 6.23
Bivalirudin for patients with acute coronary syndromes. N Engl J Med (2006) 5.49
Cystic fibrosis. Lancet (2009) 5.40
Physical activity, including walking, and cognitive function in older women. JAMA (2004) 4.90
Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet (2008) 4.35
Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med (2004) 4.09
Improving access to geriatric mental health services: a randomized trial comparing treatment engagement with integrated versus enhanced referral care for depression, anxiety, and at-risk alcohol use. Am J Psychiatry (2004) 3.28
Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr (2005) 3.26
Interpreting incomplete data in studies of diet and weight loss. N Engl J Med (2003) 3.14
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial. JAMA (2007) 3.07
A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury. Pain (2006) 2.91
Transcranial direct current stimulation of the unaffected hemisphere in stroke patients. Neuroreport (2005) 2.75
A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. Arthritis Rheum (2006) 2.74
Confocal light absorption and scattering spectroscopic microscopy monitors organelles in live cells with no exogenous labels. Proc Natl Acad Sci U S A (2007) 2.56
Translating statistical findings into plain English. Lancet (2009) 2.36
Nutrition support in the intensive care unit: an evolving science. Arch Surg (2010) 2.25
Why critically ill patients are protein deprived. JPEN J Parenter Enteral Nutr (2013) 2.03
Exposure to lead in children--how low is low enough? N Engl J Med (2003) 1.97
A sham-controlled trial of a 5-day course of repetitive transcranial magnetic stimulation of the unaffected hemisphere in stroke patients. Stroke (2006) 1.91
Genetic modifiers of liver disease in cystic fibrosis. JAMA (2009) 1.88
Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS. J Pediatr Gastroenterol Nutr (2010) 1.86
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. JAMA (2007) 1.84
Hyperglycemia in acutely ill patients. JAMA (2002) 1.77
The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype. Eur J Gastroenterol Hepatol (2008) 1.77
IQ and blood lead from 2 to 7 years of age: are the effects in older children the residual of high blood lead concentrations in 2-year-olds? Environ Health Perspect (2005) 1.75
Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin. J Clin Invest (2007) 1.73
Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol (2009) 1.70
A prospective study of floor surface, shoes, floor cleaning and slipping in US limited-service restaurant workers. Occup Environ Med (2010) 1.67
Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics (2006) 1.60
Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry. Pediatrics (2004) 1.59
Acute regulation of the SLC26A3 congenital chloride diarrhoea anion exchanger (DRA) expressed in Xenopus oocytes. J Physiol (2003) 1.59
Hyperglycemia enhances the cytokine production and oxidative responses to a low but not high dose of endotoxin in rats. Crit Care Med (2005) 1.55
Alcohol consumption among older adults in primary care. J Gen Intern Med (2007) 1.55
Pain in chronic pancreatitis: a salutogenic mechanism or a maladaptive brain response? Pancreatology (2007) 1.52
Physical compatibility of neonatal total parenteral nutrition admixtures containing organic calcium and inorganic phosphate salts in a simulated infusion at 37 degrees C. Pediatr Crit Care Med (2009) 1.52
Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function. J Pediatr (2007) 1.48
Clinical effects and brain metabolic correlates in non-invasive cortical neuromodulation for visceral pain. Eur J Pain (2010) 1.47
Inhibition of interleukin-6-activated janus kinases/signal transducers and activators of transcription but not mitogen-activated protein kinase signaling in liver of endotoxin-treated rats. Crit Care Med (2002) 1.45
Design and sample characteristics of the PRISM-E multisite randomized trial to improve behavioral health care for the elderly. J Aging Health (2004) 1.45
A controlled clinical trial of cathodal DC polarization in patients with refractory epilepsy. Epilepsia (2006) 1.43
Definitions of pediatric pancreatitis and survey of present clinical practices. J Pediatr Gastroenterol Nutr (2012) 1.43
Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology (2010) 1.33
Strategies for developing biostatistics resources in an academic health center. Acad Med (2013) 1.27
Optimizing trial design: sequential, adaptive, and enrichment strategies. Circulation (2009) 1.25
Analysis of cystic fibrosis gener product (CFTR) function in patients with pancreas divisum and recurrent acute pancreatitis. Am J Gastroenterol (2004) 1.23
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial. Eur Heart J (2009) 1.21
Direct Costs of Acute Recurrent and Chronic Pancreatitis in Children in the INSPPIRE Registry. J Pediatr Gastroenterol Nutr (2016) 1.20
Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control (2008) 1.19
Confocal light absorption and scattering spectroscopic microscopy. Appl Opt (2007) 1.18
Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol (2014) 1.18
Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. JPEN J Parenter Enteral Nutr (2004) 1.18
Decreased expression of peroxisome proliferator activated receptor gamma in cftr-/- mice. J Cell Physiol (2004) 1.17
Evidence of intestinal inflammation in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr (2010) 1.17
Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trial. Eur Neuropsychopharmacol (2007) 1.12
Detecting moderator effects using subgroup analyses. Prev Sci (2013) 1.11
Calcium and phosphate compatibility: revisited again. Am J Health Syst Pharm (2008) 1.11
Current clinical applications of omega-6 and omega-3 fatty acids. Nutr Clin Pract (2006) 1.10
Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered. Clin Diagn Lab Immunol (2004) 1.09
The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis. Hum Genet (2005) 1.08
Appropriate protein provision in critical illness: a systematic and narrative review. Am J Clin Nutr (2012) 1.05
Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial. Ann Neurol (2009) 1.04
The peroxisome deficient Arabidopsis mutant sse1 exhibits impaired fatty acid synthesis. Plant Physiol (2004) 1.04
Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. Am J Clin Nutr (2011) 1.04
Basic protocol for transepithelial nasal potential difference measurements. J Cyst Fibros (2004) 1.01
Physical compatibility of neonatal total parenteral nutrient admixtures containing organic calcium and inorganic phosphate salts. Am J Health Syst Pharm (2005) 1.01
Differences in the pattern of structural abnormalities on CT scan in patients with cystic fibrosis and pancreatic sufficiency or insufficiency. Chest (2013) 1.00
Transcranial DC stimulation coupled with TENS for the treatment of chronic pain: a preliminary study. Clin J Pain (2009) 1.00
The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells. Cancer Lett (2002) 1.00
Treatment of chronic visceral pain with brain stimulation. Ann Neurol (2005) 0.99
Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism. J Lipid Res (2008) 0.98
Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Am J Physiol Gastrointest Liver Physiol (2006) 0.97
Monocarboxylate transporter 1 deficiency and ketone utilization. N Engl J Med (2015) 0.97
Glutamine and antioxidants in critically ill patients. N Engl J Med (2013) 0.96
An international randomized multicenter comparison of nasal potential difference techniques. Chest (2010) 0.96
Elevated maternal cortisol levels during pregnancy are associated with reduced childhood IQ. Int J Epidemiol (2009) 0.95
Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis. Hum Genet (2003) 0.95
Satisfaction with mental health services in older primary care patients. Am J Geriatr Psychiatry (2006) 0.95
Hyperglycemia induced by glucose infusion causes hepatic oxidative stress and systemic inflammation, but not STAT3 or MAP kinase activation in liver in rats. Metabolism (2003) 0.94
Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients. J Cyst Fibros (2011) 0.94
Effects of protein malnutrition on IL-6-mediated signaling in the liver and the systemic acute-phase response in rats. Am J Physiol Regul Integr Comp Physiol (2004) 0.94
Essential fatty acids and their derivatives. Curr Opin Gastroenterol (2005) 0.94
The National Emphysema Treatment Trial--how strong is the evidence? N Engl J Med (2003) 0.93
Induction of colitis in cftr-/- mice results in bile duct injury. Am J Physiol Gastrointest Liver Physiol (2004) 0.93
A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA. J Lipid Res (2008) 0.93
Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis. Am J Physiol Gastrointest Liver Physiol (2006) 0.92
Nasal potential difference measurements to assess CFTR ion channel activity. Methods Mol Biol (2011) 0.92
Potential utility of plasma fatty acid analysis in the diagnosis of cystic fibrosis. Clin Chem (2006) 0.92